445 related articles for article (PubMed ID: 22903704)
21. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
[TBL] [Abstract][Full Text] [Related]
22. The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.
Lin J; Lee D; Choi Y; Lee SY
Sci Signal; 2015 Jun; 8(379):ra54. PubMed ID: 26038599
[TBL] [Abstract][Full Text] [Related]
23. RACK1 affects glioma cell growth and differentiation through the CNTN2-mediated RTK/Ras/MAPK pathway.
Yan Y; Jiang Y
Int J Mol Med; 2016 Jan; 37(1):251-7. PubMed ID: 26718491
[TBL] [Abstract][Full Text] [Related]
24. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
25. Requirements for PKC-augmented JNK activation by MKK4/7.
Lopez-Bergami P; Ronai Z
Int J Biochem Cell Biol; 2008; 40(5):1055-64. PubMed ID: 18182317
[TBL] [Abstract][Full Text] [Related]
26. PP2A regulates upstream members of the c-jun N-terminal kinase mitogen-activated protein kinase signaling pathway.
Zhao B; Sun L; Haas M; Denenberg AG; Wong HR; Shanley TP
Shock; 2008 Feb; 29(2):181-8. PubMed ID: 17693927
[TBL] [Abstract][Full Text] [Related]
27. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
[TBL] [Abstract][Full Text] [Related]
28. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.
Huynh H; Nguyen TT; Chow KH; Tan PH; Soo KC; Tran E
BMC Gastroenterol; 2003 Aug; 3():19. PubMed ID: 12906713
[TBL] [Abstract][Full Text] [Related]
29. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
30. HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.
He W; Wu Y; Tang X; Xia Y; He G; Min Z; Li C; Xiong S; Shi Z; Lu Y; Yuan Z
Oncotarget; 2016 Feb; 7(6):6727-47. PubMed ID: 26734995
[TBL] [Abstract][Full Text] [Related]
31. Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-terminal kinase pathway.
Lee SI; Boyle DL; Berdeja A; Firestein GS
Arthritis Res Ther; 2012 Feb; 14(1):R38. PubMed ID: 22353730
[TBL] [Abstract][Full Text] [Related]
32. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines.
Tournier C; Dong C; Turner TK; Jones SN; Flavell RA; Davis RJ
Genes Dev; 2001 Jun; 15(11):1419-26. PubMed ID: 11390361
[TBL] [Abstract][Full Text] [Related]
33. Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells.
Lan T; Chen Y; Sang J; Wu Y; Wang Y; Jiang L; Tao Y
Oncol Rep; 2012 Jun; 27(6):2039-44. PubMed ID: 22427012
[TBL] [Abstract][Full Text] [Related]
34. The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7.
Haeusgen W; Herdegen T; Waetzig V
Eur J Cell Biol; 2011; 90(6-7):536-44. PubMed ID: 21333379
[TBL] [Abstract][Full Text] [Related]
35. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
36. RACK1 modulates apoptosis induced by sorafenib in HCC cells by interfering with the IRE1/XBP1 axis.
Zhou T; Lv X; Guo X; Ruan B; Liu D; Ding R; Gao Y; Ding J; Dou K; Chen Y
Oncol Rep; 2015 Jun; 33(6):3006-14. PubMed ID: 25901709
[TBL] [Abstract][Full Text] [Related]
37. GNA14's interaction with RACK1 inhibits hepatocellular carcinoma progression through reducing MAPK/JNK and PI3K/AKT signaling pathway.
Xu C; Li YM; Sun B; Zhong FJ; Yang LY
Carcinogenesis; 2021 Nov; 42(11):1357-1369. PubMed ID: 34657150
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.
Nakagawa H; Hirata Y; Takeda K; Hayakawa Y; Sato T; Kinoshita H; Sakamoto K; Nakata W; Hikiba Y; Omata M; Yoshida H; Koike K; Ichijo H; Maeda S
Hepatology; 2011 Jul; 54(1):185-95. PubMed ID: 21488081
[TBL] [Abstract][Full Text] [Related]
39. MEKK1 induces c-Jun complexes that act as negative regulators for cell survival and proliferation of HCC cells.
Komoda F; Shino Y; Hirano T; Okutomi Y; Okamoto H; Hayashi Y; Suyama T; Ebara M; Saisho H; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):553-9. PubMed ID: 12168099
[TBL] [Abstract][Full Text] [Related]
40. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]